Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Massard (Strasbourg, France). Balanced indications for surgery or endobronchial therapy for typical carcinoid tumours. Annual Congress 2005 - Neuroendocrine tumours of the lung

Member's Comments

No comment yet.

Related content which might interest you: Bronchopleural fistula-risk factors and treatment after lung cancer surgery Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery Year: 2007 The surgical treatment of lung cancer Source: Eur Respir Mon; 2009: 44: 187–206 Year: 2009 Surgical resection of carcinoid lung tumours. A population based study Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 Locally advanced disease – indications and results of extended resections Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer Year: 2005 Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification Source: Eur Respir J 2012; 39: 478-486 Year: 2012 Surgical treatment of locally recurrent lung cancer Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 Surgical management of early lung cancer: the surgeon's view Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated? Year: 2005 Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer Source: International Congress 2017 – Thoracic surgery Year: 2017 Lung resection in presence of infection Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer Year: 2005 Thoracoscore fails to predict complications following elective lung resection Source: Eur Respir J 2012; 40: 1496-1501 Year: 2012 High postoperative risk after pneumonectomy in elderly patients with right-sided lung cancer Source: Eur Respir J 2002; 19: 141-145 Year: 2002 Persistent N2-disease after induction therapy does not jeopardize outcomes of pneumonectomy Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery Year: 2007 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009 SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020 Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Long time survival after resection for multiple primary lung cancers. A population-based study Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 Cardiac complications after lung resection surgery Source: Eur Respir J 2002; 20: Suppl. 38, 345s Year: 2002 The features of surgical technique under operation due to complicated lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 172s Year: 2005 Quality of life after lung resection due to malignant neoplasm in Brazilian patients Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005